926
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Circular RNA SMARCA5 functions as an anti-tumor candidate in colon cancer by sponging microRNA-552

, , , , &
Pages 689-701 | Received 31 Dec 2019, Accepted 07 Feb 2021, Published online: 22 Mar 2021

References

  • Rougier P, Andre T, Panis Y, et al. Colon cancer. Gastroentérologie Clinique et Biologique. 2006;30(2):2s24-s2s9.
  • Rhode H, Liehr T, Kosyakova N, et al. Molecular cytogenetic characterization of two murine colorectal cancer cell lines. OBM Gene. 2018;2(3):1.
  • Gu M-J, Huang Q-C, Bao C-Z, et al. Attributable causes of colorectal cancer in China. BMC Cancer. 2018;18(1):38.
  • Zhang Y, Chen Z, Li J. The current status of treatment for colorectal cancer in China: a systematic review. Medicine (Baltimore). 2017;96(40):e8242.
  • Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017;14(8):1035–1045.
  • Zeng K, Chen X, Xu M, et al. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018;9(4):417.
  • Wang X, Zhang Y, Huang L, et al. Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances.. Int J Clin Exp Pathol. 2015;8(12):16020–16025.
  • Weng W, Wei Q, Toden S, et al. Circular RNA ciRS-7—a promising prognostic biomarker and a potential therapeutic target in colorectal cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2017;23(14):3918–3928.
  • Xu H, Wang C, Song H, et al. RNA-Seq profiling of circular RNAs in human colorectal cancer liver metastasis and the potential biomarkers. Mol Cancer. 2019;18(1):8.
  • Li Z, Zhou Y, Yang G, et al. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma. Clin Chim Acta. 2019;492:37–44.
  • Kong Z, Wan X, Zhang Y, et al. Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer. Biochem Biophys Res Commun. 2017;493(3):1217–1223.
  • Yu J, Xu Q-G, Wang Z-G, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–1227.
  • Wang Y, Li H, Lu H, et al. <p>Circular RNA SMARCA5 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by miR-19b-3p/HOXA9 axis. <![cdata[oncotargets and Therapy]]>. 2019;12:7055–7065.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. methods. 2001;25(4):402–408.
  • Liu H, Wu Y, Wang S, et al. Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767–5p. BMC Cancer. 2019;19(1):937.
  • Cao J, Yan X-R, Liu T, et al. MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer. Oncol Lett. 2017;14(3):3795–3802.
  • Tian -J-JDC, Liang L. Involvement of circular RNA SMARCA5/microRNA-620 axis in the regulation of cervical cancer cell proliferation, invasion and migration.. Eur Rev Med Pharmacol Sci. 2018;22(24):8589–8598.
  • Barbagallo D, Caponnetto A, Cirnigliaro M, et al. CircSMARCA5 inhibits migration of glioblastoma multiforme cells by regulating a molecular axis involving splicing factors SRSF1/SRSF3/PTB. Int J Mol Sci. 2018;19(2):480. .
  • Wang Y, Li H, Lu H, et al. Circular RNA SMARCA5 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by miR-19b-3p/HOXA9 axis. Onco Targets Ther. 2006;30:24–29.
  • Dudekula DB, Panda AC, Grammatikakis I, et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13(1):34–42.
  • Cai W, Xu Y, Yin J, et al. miR-552–5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1.. Exp Ther Med. 2019;17(5):3781–3788.
  • Wang N, Liu W. Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.. Eur Rev Med Pharmacol Sci. 2018;22(2):412–416.
  • Sebio A, Kahn M, Lenz H-J. The potential of targeting Wnt/β-catenin in colon cancer. Expert Opin Ther Targets. 2014;18(6):611–615.
  • Ahmad R, Kumar B, Chen Z, et al. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling. Oncogene. 2017;36(47):6592–6604.
  • Voloshanenko O, Erdmann G, Dubash TD, et al. Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells. Nat Commun. 2013;4(1):2610. .
  • Shibata M, Ham K, Hoque MO. A time for YAP1: tumorigenesis, immunosuppression and targeted therapy. Int J Cancer. 2018;143(9):2133–2144.
  • Cho SY, Gwak JW, Shin YC, et al. Expression of Hippo pathway genes and their clinical significance in colon adenocarcinoma.. Oncol Lett. 2018;15(4):4926–4936. .
  • Wang L, Shi S, Guo Z, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PloS One. 2013;8(6):e65539.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.